I will decline the invitation to accept Steve’s promise

New Post Public Reply Private Reply Replies (1) Message Board
JayDee Snark #20646
615
I will decline the invitation to accept Steve’s promise that her will one day perform in lieu of actual performance.

No rush to condemn. The only way condemnation would be “rushed” is if there had been no actual developments to condemn. I am reacting to actual developments and actual facts, not speculation. From an investor’s perspective, and that’s what we are, investors, not a self-help therapy group, the biggest mistake is a rush to validate, not a rush to condemn. My trust isn’t owed to anyone, it is earned by a few.

To me it defies credulity that after all we have been through, and with so much on the line, QTMM would not file its quarterlies and annuals. The SEDC couldn’t have stated more clearly and reiterated several times: if Steve doesn’t file QTMM’s quarterlies and annuals, QTMM’s registration will be revoked. Steve promised he was working diligently on the filings and we could expect a positive update soon. We found out very soon he was off the mark. In unmistakable terms. Having failed to perform on his promises time and again, having caused QTMM’s registration to be revoked, I feel much the way the SEC did. Where Steve is concerned, only performance will earn QTMM the status of “back on track,” not a Steven Squires promise which has been characteristically couched between buck-passing, double-talk and a few weak excuses. Yes, I see a pocket—an empty one. And that is precisely where you and I part company. I see an empty pocket. Apparently, you see Jesus.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Innovative Thought Leadership: TLFT 2025 Awards

Updated Category News Views 401

Celebrating Innovative Thought Leadership Accenture, KPMG, and Elsevier have been honored for their groundbreaking accomplishments in thought leadership, showcasing their significant influence across brand development, social impact, and industry standards. Recognition at the TLFT 2025 Awards iResearch Services has proudly unveiled the winners of the prestigious TLFT 2025...

Continue Reading
Aquestive Therapeutics Boosts Stock Target After Event Insights

Updated Category News Views 57

Aquestive Therapeutics made headlines back in 2024 with its stock getting a price target bump to $10 from H.C. Wainwright. This was right after they rolled out updates at a virtual investor event where they pitched their cutting-edge Adrenaverse technology. Traders were buzzing—was this the kind of news that’d drive shares up? Turns out, it was more than just fluff;...

Continue Reading
Valneva Collaborates with LimmaTech on Shigella Vaccine Study

Updated Category News Views 63

Valneva Begins Clinical Trials for Innovative Shigella Vaccine Valneva SE, a prominent specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech firm, have recently marked a significant milestone in vaccine research. They announced the initial vaccination in a pivotal Phase 2b controlled human infection model (CHIM) study focused on their tetravalent...

Continue Reading
Innovative Vehicle Accessory Enhances Road Safety Efforts

Updated Category News Views 194

Introducing a Revolutionary Vehicle Safety Accessory Every day, drivers encounter various challenges on the road, from navigating busy intersections to spotting pedestrians or hidden traffic signs. An innovative inventor recognized these challenges and developed the CORNER CAMERA, an inventive solution aimed at improving road safety for everyone. Understanding the CORNER...

Continue Reading
California Northstate University Celebrates Key Accreditation Milestone

Updated Category News Views 159

California Northstate University Announces Full Accreditation California Northstate University (CNU) has achieved a significant milestone by securing full accreditation for its College of Medicine from the Liaison Committee on Medical Education (LCME). This achievement underscores CNU’s unwavering dedication to promoting educational excellence, innovation, and the...

Continue Reading